Table 2.

Paraclinical characteristics of the entire cohort of patients with AL systemic amyloidosis

Paraclinical characteristics of the cohort
Hemoglobin, mg/dL, median (range) 12.3 (7.3-15.2) 
Serum creatinine, mg/dL, median (range) 1.01 (0.5-16.2) 
Serum creatinine >1.5, n (%) 6 (18) 
Platelets, /mm3, median (range) 302 500 (110 000-985 000) 
eGFR, mL/min per 1.73 m2, median (range) 69.5 (3-112) 
Protein in urine 24 hours, median (range), g/d 3 (0-15.2) 
Protein in urine >3500, mg/d, n (%) 13 (48) 
Beta-2 microglobulin, mg/dL, median (range) 3.6 (0.6-1347) 
Alkaline phosphatase, medium (range) 109 (52-365) 
Monoclonal peak in gamma region, g/dL, median (range) 0.85 (0.2-5.9) 
Kappa light chains, mg/dL, median (range) 41.5 (0.6-578) 
Lambda light chains, mg/dL, median (range) 103.365 (1.5-5999.4) 
Difference between affected and unaffected light chain, median (range) 151.65 (0.88-5957.2) 
Lactate dehydrogenase, median (range) 221 (15-424) 
NT-proBNP, pg/mL, median (range) 1929 (5.9-19708) 
hs-cTnI, ng/mL, median (range) 25 (0.0034-482) 
Plasma cells in bone marrow, %, median (range) 10 (1-80) 
Plasma cells in bone marrow >30%, n (%) 4 (14) 
Paraclinical characteristics of the cohort
Hemoglobin, mg/dL, median (range) 12.3 (7.3-15.2) 
Serum creatinine, mg/dL, median (range) 1.01 (0.5-16.2) 
Serum creatinine >1.5, n (%) 6 (18) 
Platelets, /mm3, median (range) 302 500 (110 000-985 000) 
eGFR, mL/min per 1.73 m2, median (range) 69.5 (3-112) 
Protein in urine 24 hours, median (range), g/d 3 (0-15.2) 
Protein in urine >3500, mg/d, n (%) 13 (48) 
Beta-2 microglobulin, mg/dL, median (range) 3.6 (0.6-1347) 
Alkaline phosphatase, medium (range) 109 (52-365) 
Monoclonal peak in gamma region, g/dL, median (range) 0.85 (0.2-5.9) 
Kappa light chains, mg/dL, median (range) 41.5 (0.6-578) 
Lambda light chains, mg/dL, median (range) 103.365 (1.5-5999.4) 
Difference between affected and unaffected light chain, median (range) 151.65 (0.88-5957.2) 
Lactate dehydrogenase, median (range) 221 (15-424) 
NT-proBNP, pg/mL, median (range) 1929 (5.9-19708) 
hs-cTnI, ng/mL, median (range) 25 (0.0034-482) 
Plasma cells in bone marrow, %, median (range) 10 (1-80) 
Plasma cells in bone marrow >30%, n (%) 4 (14) 

eGFR, estimated glomerular filtration rate; hs-cTnI, high-sensitivity assay for troponin I; NT-proBNP, N-terminal pro-B-type natriuretic peptide.

or Create an Account

Close Modal
Close Modal